Evidence map›Paper›PMID 30150786›Full record

ArticleScientific reports2018

Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model.

Makoto Ishikawa, Takeshi Yoshitomi, Douglas F Covey, Charles F Zorumski, Yukitoshi Izumi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. New directions in neurosteroid therapeutics in neuropsychiatry.Neuroscience and biobehavioral reviews · 2025
    Review
  2. Article
  3. Oxysterols in Central and Peripheral Synaptic Communication.Advances in experimental medicine and biology · 2024
    Article
  4. Article
  5. A lab-on-a-chip model of glaucoma.Brain and behavior · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Makoto IshikawaDepartment of Ophthalmology, Akita University Graduate School of Medicine, Akita, Japan. mako@med.akita-u.ac.jp.
Takeshi YoshitomiDepartment of Ophthalmology, Akita University Graduate School of Medicine, Akita, Japan.
Douglas F CoveyDepartment of Developmental Biology, Washington University School of Medicine, St. Louis, M.O, USA.
Charles F ZorumskiThe Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, M.O, USA.
Yukitoshi IzumiThe Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, M.O, USA.
Akita University · JPTaylor Family Institute for Innovative Psychiatric ResearchWashington University in St. Louis · US

Funding

MODULATION OF HIPPOCAMPAL SYNAPTIC PLASTICITYR01MH077791 · NIMH · WASHINGTON UNIVERSITY · PI ZORUMSKI, CHARLES F · 2007 to 2013
$2.4M
Oxysterols and NMDAR FunctionR01MH101874 · NIMH · WASHINGTON UNIVERSITY · PI MENNERICK, STEVEN J, ZORUMSKI, CHARLES F · 2014 to 2018
$1.9M
Japan Society for the Promotion of Science (JSPS) 15K10888Japan Society for the Promotion of Science (JSPS) 18K09438NIMH NIH HHS R01 MH077791NIMH NIH HHS R01 MH101874U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH077791U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH101874
6 · The paper itself

Abstract

In a rat ex vivo acute glaucoma model, high pressure (75 mmHg) causes swelling of ganglion cell axons and elevates levels of the endogenous steroids 24(S)-hydroxycholesterol (24SH) and allopregnanolone (AlloP). Furthermore, 24SH (0.1 µM) alone elevates AlloP levels via NMDA receptors. With this model, we now investigate possible interactions between 24SH and AlloP. We found that inhibition of AlloP synthesis with dutasteride under high pressure results in severe excitotoxicity in addition to axonal swelling. The excitotoxicity is prevented by exogenous AlloP but not 24SH, indicating that endogenous AlloP is crucial for protection. However, inhibition of 24SH synthesis with voriconazole induces severe excitotoxicity under normal pressure. Paradoxically, the excitotoxicity by voriconazole is better prevented by AlloP than 24SH. These findings suggest that inhibition of 24SH synthesis becomes excitotoxic in the absence of AlloP. We also observed that co-administration of sub-micromolar 24SH (0.1 µM) and AlloP (0.1 µM), concentrations that are only partially effective when administered alone, prevents axonal swelling under high pressure. This apparent enhanced protection indicates strong interaction between the two neurosteroids to preserve neuronal integrity, with 24SH contributing to AlloP synthesis via NMDA receptors and with AlloP playing an essential role in neuroprotection via GABA

Indexed as

AnimalsApoptosisBiomarkersBiosynthetic PathwaysCell SurvivalGlaucomaHydroxycholesterolsMaleNeuronsNeuroprotective AgentsNeurotransmitter AgentsOptic NervePregnanoloneRatsReceptors, GABAReceptors, N-Methyl-D-AspartateBiomarkersHydroxycholesterolsNeuroprotective AgentsNeurotransmitter AgentsPregnanoloneReceptors, GABAReceptors, N-Methyl-D-Aspartate

Identifiers

PMID30150786
PMCPMC6110753
OpenAlexW2888450856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.